+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Safety Needles Market - Forecasts from 2022 to 2027

  • PDF Icon


  • 117 Pages
  • March 2022
  • Region: Global
  • Knowledge Sourcing Intelligence LLP
  • ID: 5576457
The global safety needles market was valued at US$381.804 million in 2020 and is forecasted to reach US$910.035 million by 2027, growing at a CAGR of 13.21%.

Safety needles are advanced needs having the feature of an inbuilt safety mechanism that has the capability to avoid needle-linked injuries to the patients. The prime reason which is expected to drive the market growth during the forecasted period is the growing advent of diseases and rising vaccination in an attempt to avoid chronic diseases. With rising complexities in lifestyle and the growing prevalence of chronic diseases, expenditure on diagnosis, treatments, and vaccinations has surged significantly, which has increased the market for safety needles. Furthermore, demand for single-use safety needles for better prevention against potential infection of unwanted pathogens entering the body has provided a new opportunity for growth for the industry. Moreover, an increase in the geriatric population and demand for safe needles for better body suitability also drive the market growth. Robust investment by the government in the healthcare sector is also projected to provide stable growth.

Geographically, the global safety needles are divided into North America, South America, Europe, the Middle East and Africa, and the Asia Pacific regions for the study. The Asia Pacific and North American regions are expected to hold a significant market share. The Asia Pacific region has been emerging as a medical hub. Compared to their countries, Americans and the European population find medical treatment in this region more cost-effective and cheap. An average American can save up to 90% of the expenditure on healthcare if the patient gets treatment from the Asia Pacific region. Furthermore, rising healthcare infrastructure and facilities in the region will further expand the medical tourism market and provide substantial growth for safety needles.

The European region has observed a high rise in the proportion of the geriatric population and a significant increase in chronic, especially cardiovascular disease, which is projected to create the demand for safety syringes for diagnosis, treatment, and medicines intake.  

Growth Factor

Rising healthcare expenditure and instances of diseases.

One of the prime reasons driving the market growth of safety needles is rising healthcare expenditure and instances of diseases. With growing complexities in lifestyle, a surge in cases of cardiovascular diseases has increased. Diagnosis, treatment, and medicine intake have increased significantly, which has raised safety needle adaption. Data from World Health Organization (WHO) shows that in 2019, 17.9 patients lost their lives owing to cardiovascular illnesses, which accounted for 32% of deaths in the year. 6.460 million deaths among patients under 65 years of age were caused by CVDs.  Rising instances of chronic diseases have significantly increased health expenditure for better healthcare. Data from World Bank shows that per capita health expenditure has increased globally from US$999.104 in 2015 to US$1,111.082 in 2018. Increasing health expenditure and treatment are expected to surge the market for safety needles. Furthermore, international organizations have also taken the initiative to reduce the burden of chronic diseases through awareness programs, medication, and treatments. WHO aims to reduce the global prevalence of blood pressure issues by 25% from 2010 to 2025. WHO had declared that 50% of the beneficiaries under this program will receive continuous drug therapy and other treatments to prevent CVDs linked death by 2025. Promising prevention and treatment prospects are expected to increase the market opportunities.

Market Restraint

Rising syringe and needle waste create an environmental threat.

A major problem faced by the safety needle industry is the disposal of needles. Safety syringes are dominantly single-use syringes, and their improper disposal creates syringes and needles pollution. With the rising usage of needles and syringes, a surge in syringe pollution has been observed worldwide. In March 2021, San Francisco collected more than 13,000 syringes and needles waste, an increase of 10 times than a decade ago. Furthermore, improper disposal of needles raises the chances of spreading diseases such as HIV and hepatitis. The surging needles market is expected to increase further pollution, which degrades the environment and hence has raised concerns.

COVID-19 Insights

The coronavirus pandemic boosted the demand for safe needles globally. With the outbreak of the virus, the medical industry indulged in the formulation of vaccines and treatments to prevent the spread of the virus. The discovery of covid vaccines in late 2020 and the surging demand for vaccination boosted the market demand for safety needles. Data from Our World in Data shows that globally, till September 2021, 44.1% of the global population has received at least one dose of the covid vaccine. Rising vaccination has increased the demand for syringes and needles, which will boost the market for safe needles in the next couple of years.

Key Market Segments

By Type

  • Active Safety Needles
  • Passive Safety Needles

By Route Of Administration

  • Subcutaneous 
  • Intravenous
  • Others

By End Users

  • Hospitals and clinics
  • Ambulatory care centers
  • Diagnostic centers
  • Others

By Geography

  • North America
  • USA
  • Canada
  • Mexico
  • South America
  • Brazil
  • Argentina
  • Others
  • Europe
  • United Kingdom
  • Germany
  • Spain
  • France
  • Others
  • Middle East and Africa
  • UAE
  • Saudi Arabia
  • Others
  • Asia Pacific
  • Japan
  • China
  • India
  • South Korea
  • Taiwan
  • Thailand
  • Indonesia
  • Others
Frequently Asked Questions about the Global Safety Needles Market

What is the estimated value of the Global Safety Needles Market?

The Global Safety Needles Market was estimated to be valued at $381.8 million in 2020.

What is the growth rate of the Global Safety Needles Market?

The growth rate of the Global Safety Needles Market is 13.2%, with an estimated value of $910.04 million by 2027.

What is the forecasted size of the Global Safety Needles Market?

The Global Safety Needles Market is estimated to be worth $910.04 million by 2027.

Who are the key companies in the Global Safety Needles Market?

Key companies in the Global Safety Needles Market include BD, Cardinal Health, B. Braun Melsungen Ag, Medline Industries, Inc., Johnson & Johnson Services, Inc., Nipro Medical Corporation, Smiths Group Plc, Métier Medical Limited and Olympus Corporation.

Table of Contents

1. INTRODUCTION1.1. Market Definition
1.2. Market Segmentation

2.2. Assumptions

3. EXECUTIVE SUMMARY3.1. Research Highlights

4. MARKET DYNAMICS4.1. Market Drivers
4.2. Market Restraints
4.3. Porters Five Forces Analysis
4.3.1. Bargaining Power of Suppliers
4.3.2. Bargaining Powers of Buyers
4.3.3. Threat of Substitutes
4.3.4. The Threat of New Entrants
4.3.5. Competitive Rivalry in Industry
4.4. Industry Value Chain Analysis

5.2. Active Safety Needles
5.3. Passive Safety Needles 

6.2. Subcutaneous  
6.3. Intravenous
6.4. Others 

7.2. Hospitals and clinics
7.3. Ambulatory care centers
7.4. Diagnostic centers
7.5. Others 

8.2. North America
8.2.1. United States
8.2.2. Canada
8.2.3. Mexico
8.3. South America
8.3.1. Brazil
8.3.2. Argentina
8.3.3. Others
8.4. Europe
8.4.1. Germany
8.4.2. France
8.4.3. United Kingdom 
8.4.4. Spain 
8.4.5. Others
8.5. Middle East and Africa
8.5.1. Saudi Arabia
8.5.2. UAE
8.5.3. Israel
8.5.4. Others
8.6. Asia Pacific
8.6.1. China
8.6.2. India
8.6.3. South Korea
8.6.4. Taiwan
8.6.5. Thailand
8.6.6. Indonesia 
8.6.7. Japan
8.6.8. Others

9. COMPETITIVE ENVIRONMENT AND ANALYSIS9.1. Major Players and Strategy Analysis
9.2. Emerging Players and Market Lucrativeness
9.3. Mergers, Acquisition, Agreements, and Collaborations
9.4. Vendor Competitiveness Matrix

10.2. Cardinal Health
10.3. B. Braun Melsungen Ag
10.4. Medline Industries, Inc.
10.5. Johnson & Johnson Services, Inc.
10.6. Nipro Medical Corporation
10.7. Smiths Group Plc
10.8. Métier Medical Limited
10.9. Olympus Corporation

Companies Mentioned

  • BD
  • Cardinal Health
  • B. Braun Melsungen Ag
  • Medline Industries, Inc.
  • Johnson & Johnson Services, Inc.
  • Nipro Medical Corporation
  • Smiths Group Plc
  • Métier Medical Limited
  • Olympus Corporation